Here are relevant reports on : mental-health-app-market
-
Larvicides Market by Control Method (Biocontrol Agents, Chemical Agents, Insect Growth Regulators), Target (Mosquitoes, Flies), End-use Sector (Public Health, Agricultural, Commercial, Residential, Livestock), and Region - Global Forecast to 2023
The larvicides market is estimated at USD 751.6 Million in 2018, and is projected to reach USD 952.7 Million by 2023, at a CAGR of 4.86% during the forecast period. The market is primarily driven by factors such as vector-based epidemics or outbreaks, climatic changes, the rise in pest population, worldwide, and growth in awareness about IPM practices and environmental sustainability. This report includes a study of marketing and development strategies, along with the product portfolios of leading companies which includes Bayer (Germany), BASF (Germany), Gowan Company (US), Sumitomo Chemical (Japan), Nufarm (Australia), Certis (US), Summit Chemical (US), Syngenta (Switzerland), Adama (Israel), Eli Lily and Company (US), Russell IPM (UK), and Central Garden & Pet Co. (US).
- Published: May 2018
- Price: $ 4950
- TOC Available:
-
Patient Engagement Technology an Innovative Tool for Healthcare Industry, Global End User Market Trends and Analysis - (Price Analysis, Replacement Trends and Factor Analysis, Selection Criteria, Buying Behavior and Mobile health)
The global patient engagement technology market growth is primed to transition from $17.3 billion in 2022 to $27.9 billion by 2027, showcasing a strong CAGR of 10.0%.
- Published: September 2022
- Price: $ 4950
- TOC Available:
-
Precision Biotics Market by Type (Precision Probiotics, Next-generation Probiotics, Synbiotics, Postbiotics), End-use Industry, Health/Functional Positioning, Distribution Channel, and Region - Global Forecast to 2031
The precision biotics market is estimated at USD 4.91 billion in 2026 and is projected to reach USD 9.26 billion by 2031, at a CAGR of 13.5% from 2026 to 2031. The report profiles key players such as BioGaia (Sweden), Novonesis Group (Denmark), Procter & Gamble (US), Unilever (UK), dsm-firmenich (Switzerland), Metagenics, LLC (US), Yakult Honsha Co., Ltd (Japan), Danone (France), KANEKA CORPORATION (Japan), Symrise (Germany)-(Probi), Jarrow Formulas, Inc (US), Pendulum (US), thegoodbug (India), Seed Health, Inc (US), and Infinant Health Inc (US).
- Published: July 2026
- Price: $ 4950
- TOC Available:
-
Asia Pacific Patient Engagement Solutions Market by Therapy (Chronic [Obesity, Diabetes], Women’s Health), Functionality (Telehealth, E-Prescribing, Scheduling, Billing), End User (Hospital, ASC, Payer, Patient), Unmet Need, Investment - Forecast to 2030
The Asia Pacific Patient Engagement Solutions market, valued at USD 3.45 billion in 2024, stood at USD 3.97 billion in 2025 and is projected to advance at a resilient CAGR of 13.5% from 2025 to 2030, culminating in a forecasted valuation of USD 7.48 billion by the end of the period. This growth is driven by the rising demand for patient-centered and personalized care, a rapid expansion of telehealth and remote care frameworks, and more investments in digital healthcare infrastructure within the Asia Pacific region.
- Published: October 2026
- Price: $ 4950
- TOC Available:
-
Pet Supplements Market by Functional Application (Skin & Coat, Hips & Joints, Digestive Health, Immune Support), Supplement Type (Multivitamin, Glucosamine, Antioxidants), Pet, Form, Distribution Channel, and Region - Global Forecast to 2029
According to MarketsandMarkets, the global pet supplements market is estimated to be valued at USD XXX.X million in 2024 and is projected to reach USD XXX.X million by 2029, recording a CAGR of X.X%. Key players in this market include ADM (US), Nestlé (Switzerland), Nutramax Laboratories, Inc. (US), Zoetis Services LLC (US), Virbac (France), Zesty Paws (US), These players have adopted strategies of product launches, expansions, agreements/partnerships, and mergers and acquisitions to grow in the market. All key product manufacturers that are part of the pet supplements ecosystem have been considered under the company profiles section.
- Published: November 2026
- Price: $ 4950
- TOC Available:
-
Companion Animal Health Market by Animal Type (Dogs, Cats), Product (Vaccines, Pharmaceuticals, Diagnostics), End User (Veterinary Hospitals & Clinics, Diagnostics Laboratories) - Global Forecast to 2027
The companion animal health market is projected to reach USD 26.9 Billion by 2027 from USD 19.2 Billion in 2022 at a CAGR of 6.9% during the forecast period. The growth in this market is mainly attributed to increasing companion animal population, rising demand for pet insurance, growing animal health expenditure, and the increasing number of veterinary practitioners & their rising income level in developed countries. However, increasing pet care costs are expected to hinder market growth to a certain extent.
- Published: November 2026
- Price: $ 4950
- TOC Available:
-
Essential Oils Market by Product Type, Application (Food & beverages, Cosmetics & Toiletries, Aromatherapy, Home Care, and Health Care), Source (Fruits & Vegetables, Herbs & Spices, Flowers), Method of Extraction and Region - Global Forecast to 2027
The global essential oils market size is projected to reach USD 15.3 billion by 2027, recording a CAGR of 11.8% during the forecast period. This report includes a study on the marketing and development strategies, along with the product portfolios of leading companies. It consists of profiles of leading companies, such as Cargill, Incorporated (US), DSM (Netherlands), Givaudan (Switzerland), International Flavors & Fragrances Inc. (US), Sensient Technologies Corporation (US), Symrise (Germany), Robertet SA (France), MANE (France), doTERRA (US), NOW Foods (US), Lebermuth, Inc. (US), BIOLANDES (France), Norex Flavours Private Limited (India) and India Essential Oils (India).
- Published: September 2022
- Price: $ 4950
- TOC Available:
-
Microservices in Healthcare Market by Component (Platform, Services (Consulting, Integration, Training, Support, Maintenance)), Delivery (Cloud, Hybrid, Private, On-premise), End User (Health care Provider, Payer, Life Science) - Global Forecast to 2023
The microservices in healthcare market is projected to reach USD 343.3 million by 2023, growing at a CAGR of 21.3%. The benefits of microservice architecture, such as their ability to increase overall efficiency and project delivery speed, are the primary factor driving the market growth. However, concerns regarding security and regulatory compliance and the complexity of architecture are expected to hinder the growth of this market. The microservices in healthcare market is marked by the presence of several big and small players. Prominent players in this market include AWS (US), CA Technologies (US), Microsoft (US), Salesforce (US), Pivotal Software (US), Infosys (India), IBM (US), NGINX (US), Oracle Corporation (US), and Syntel (US).
- Published: October 2018
- Price: $ 4950
- TOC Available:
-
Digestive Health Ingredients Market, By Type (Digestive Enzymes, Probiotics, Prebiotics, Zinc Carnosine) By Application (Beverages, Bakery, Dairy and Others) By Geography
- Published: November 2026
- Price: $ 4950
- TOC Available:
-
Eubiotics Market by Type (Probiotics, Prebiotics, Organic Acids, Essential Oils), Livestock (Swine, Poultry, Ruminant, Aquaculture), Form (Dry and Liquid), Function (Nutrition & Gut Health, Yield, Immunity, Production) - Global Forecast to 2022
The eubiotics market is projected to grow at a CAGR of 7.51% to reach USD 7.47 Billion by 2022. The market is driven by factors such as increase in awareness about feed quality and safety, rise in demand for manufactured animal feed, growth in demand for animal high protein, change in framing practices and technology, and replacing antibiotic growth promoters (AGPs) with eubiotics. Continuous rise in the population also results in increase in the demand for food and the necessity for eubiotics, to increase the meat and milk in a sustainable manner.
- Published: December 2016
- Price: $ 4950
- TOC Available:
Records 41 to 50 of 50
